UBS O'Connor’s MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share MDH.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-154,128
Closed -$71K 1175
2021
Q4
$71K Buy
154,128
+4,134
+3% +$2.44K ﹤0.01% 881
2021
Q3
$83K Hold
149,994
﹤0.01% 848
2021
Q2
$116K Buy
+149,994
New +$90.7K ﹤0.01% 805

Other funds holding MDH.WS

UBS O'Connor's MDH.WS Position: Q1 2022 in Review

UBS O'Connor sold out of MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (MDH.WS) in Q1 2022, closing a stake of 154,128 shares — an estimated $71K sold.

UBS O'Connor first reported a position in MDH.WS in Q2 2021 and held it in 3 quarters. The position peaked at $116K in Q2 2021. 52 funds tracked by Wall St. Rank hold MDH.WS as of Q1 2022.

  • UBS O'Connor reported no remaining MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 154,128 MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q1 2022, an estimated $71K.
  • UBS O'Connor first reported a position in MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q2 2021 and held it in 3 quarters.
  • UBS O'Connor's MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $116K in Q2 2021.
  • 52 funds tracked by Wall St. Rank held MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.